South African pharmaceutical company Aspen Pharmacare announced on Monday, December 29th, the sale of its main Asia-Pacific operations (excluding China) to Australian private equity fund BGH Capital for 2.37 billion Australian dollars, approximately 1.59 billion US dollars. This transaction, which includes markets in Australia, New Zealand, Hong Kong, Taiwan, Malaysia, and the Philippines, is part…...
Trending
- Exclusive Interview – Thierno Habib Hann, CEO of Shelter Afrique Development Bank
- CIMA Zone: Senegal becomes the second largest insurance market, with a turnover of 311 billion FCFA
- S&P confirms Afreximbank’s investment grade rating with BBB+
- CEMAC: Weak collection of community tax threatens the functioning of institutions
- Equatorial Guinea: Nearly $355 million in savings thanks to the revision of construction costs
- Creditinfo Central Africa establishes itself in Chad
- Ghana International Bank appoints Ian Greenstreet as its CEO
- Angola Telecom and Telecom Namibia invest 118 million USD in a regional submarine link
